Fast Five Quiz: Amyloid-Related Imaging Abnormalities in Alzheimer's Disease

Jasvinder P. Chawla, MD, MBA


August 28, 2023

Alzheimer's disease (AD) is the most common form of dementia.

Biologically, AD is defined by the presence of β-amyloid (Aβ)-containing plaques and tau-containing neurofibrillary tangles, which is evident in brain imaging. Although AD is a clinical diagnosis, neuroimaging has begun to play an increasingly important role not only to facilitate diagnosis once symptoms are present but also to help determine underlying disease etiology. Characteristic changes in the brain that are present in the prodromal and even preclinical stage might help to provide clues to the most effective treatment and potential outcomes for each patient.

How much do you know about amyloid-related imaging abnormalities in AD? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.